CAI0019 is an orally active alpha-carbonic anhydrase inhibitor based on the Acetazolamide (HY-B0782) framework. CAI0019 exhibits narrow-spectrum antibiofilm activity, with its MIC50 being 0.094 µM and MIC90 being 0.39 µM. CAI0019 selectively inhibits Enterococcus in a septic peritonitis mouse model, without affecting most intestinal commensal bacteria[1].
Molekulargewicht:
318.42
CAS Nummer:
[2446169-48-6]
Formel:
C11H18N4O3S2
Target-Kategorie:
Bacterial,Carbonic Anhydrase,Drug Derivative
Anwendungsbeschreibung:
MCE Product type: Reference compound
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten